Jason Assad

Jason Assad has a diverse work experience in various industries. Jason started their career in 2000 as the President of C&H Capital Inc., where they provided seed financing and strategic advisory services. In 2018, they became the Head of Corporate Communications at Amergent Hospitality Group, Inc. Jason has also held positions as the Director of Corporate Communications at TeraWulf and Unrivaled Brands, where they focused on developing effective communication strategies. In the biotechnology sector, they served as the Head of Corporate Communications at Crown Electrokinetics and Gain Therapeutics, as well as a Communications Strategist at Coya Therapeutics, Inc. and Processa Pharmaceuticals. Jason is currently the Director of Corporate Communications at 180 Life Sciences and the Head of Investor Relations at Hoth Therapeutics, Inc. Through their various roles, Jason has gained expertise in areas such as investor relations, public relations, crisis management, and strategic communications.

Jason Assad attended The University of Georgia from 1989 to 1993, where they obtained a Bachelor's Degree in Public Relations.